Liaoyuan Yinying Pharmaceutical Co., Ltd., established on 1999-08-23, Business scope includes:Production,Sales API(Ethacridine lactate,Metoclopramide,Clopidogrel bisulfate,Solifenacin Succinate,Tadalafil,Paroxetine Hydrochloride,Tamsulosin Hydrochloride,Esomeprazole Magnesium,Sodium p-aminosalicylate,metaraminol bitartrate,Esomeprazole Sodium,pitavastatin calcium,ursodeoxycholic acid,Ambroxol hydrochloride)(The drug production license is valid until2020year12moon31end of day)Dolutegravir sodium,biclavir sodium,Moxifloxacin hydrochloride,Salmeterol,vilantero,Topinostat,Dexmedetomidine Hydrochloride,Carboplatin,Gemcitabine Hydrochloride,Irinotecan Hydrochloride,Oxaliplatin,Palonosetron Hydrochloride,Zoledronic acid,Levetiracetam,Atorvastatin Calcium,Sacubitril Valsartan Sodium,Pazopanib,Tofacitinib citrate,Afatinib maleate,Regorafenib(The operating permit).Export self-produced products within the business scope of the enterprise,Imported production,Raw and auxiliary materials required for scientific research,Equipment,Instrumentation,Parts and related technologies;API processing and pharmaceutical consulting services(Do not carry out medical diagnosis and treatment activities).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).